ClinicalTrials.gg
RecruitingNCT07926802Updated Nov 9, 2026

Impact of External Workplace Violence on the Occupational Well-being of Healthcare Workers

An observational study in Workplace Violence and Burnout, Professionals, sponsored by Consorci Sanitari de l'Alt Penedès i Garraf. Recruiting at 7 sites in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Consorci Sanitari de l'Alt Penedès i Garraf · Observational

From the registry’s dates

  • Started Feb 2026; still recruiting 8 months later.
Updated Nov 9, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
442
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to learn whether external workplace violence (violence by patients, relatives, or companions) is associated with poorer occupational well-being in healthcare workers aged 18 years or older who have regular face-to-face contact with patients or their families. The main questions it aims to answer are:

  • Do healthcare workers who have experienced external workplace violence in the past 12 months report more negative effects of work (somatization, exhaustion, and alienation) than those who have not?
  • How common is external workplace violence, what types occur (physical, verbal, symbolic, digital, or economic), and how intense are they?
  • Is external workplace violence associated with working conditions and organizational practices? Researchers will compare healthcare workers who have experienced external workplace violence with those who have not to see if their occupational well-being scores differ.

Participants will complete a single anonymous online survey about their experience of workplace violence, their occupational well-being, their working conditions, and the measures they consider most effective to reduce violence.

Read the detailed description

This multicenter cross-sectional study will be conducted in seven healthcare organizations with different profiles. Participants will be randomly selected from the staff census of each center, stratified by area or department, and invited to complete an anonymous online survey hosted on the REDCap platform of the sponsor. The survey includes the collateral effects dimension of the General Occupational Well-being Questionnaire (cBLG; somatization, exhaustion, and alienation scales; total score 13-91), 22 items of the Working Conditions Questionnaire (cCT; score 0-220), 6 ad hoc items on organizational practices (score 0-60), self-reported workplace violence in the past 12 months by type and intensity, and sociodemographic and occupational variables.

The primary analysis will compare mean collateral effects scores between workers with and without external workplace violence using Student's t test, followed by multivariable analyses adjusted for sex, age group, professional category, care setting, work shift, type of contract, and seniority. Subgroup analyses by sex, professional category, and center, and a dose-response analysis by violence intensity, are planned.

02

Conditions studied

  • Workplace Violence
  • Burnout, Professionals

Keywords

  • healthcare workers
  • occupational well-being
  • aggression; patient violence
03

In context

Burnout, Psychological

467 studies on the registry are indexed under Burnout, Psychological; 121 are open to participants now.

This study's planned enrollment of 442 is above the median of 200 across 117 observational studies indexed under Burnout, Psychological.

Browse Burnout, Psychological studies →

Lead sponsor

Consorci Sanitari de l'Alt Penedès i Garraf is the lead sponsor of 41 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Active healthcare workers of the participating centers whose work involves direct and regular contact with external users (patients, relatives, or companions), including clinical, technical, auxiliary, and administrative or front-desk staff

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older
  • At least 12 months of employment at the study center
  • Active healthcare worker whose work involves direct and regular contact with external users (patients, relatives, or companions), defined as at least one face-to-face interaction on 2 or more days in a typical working week

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the study
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
442 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthcare workers with external workplace violence

    Workers who self-report at least one episode of external workplace violence (physical, verbal, symbolic, digital, or economic) in the past 12 months

  • Healthcare workers without external workplace violence

    Workers who report no episodes of external workplace violence in the past 12 months

06

What researchers measure

Primary outcomes

  1. Collateral effects of work (occupational well-being)

    Sum of the somatization (5 items), exhaustion (4 items), and alienation (4 items) scales of the collateral effects dimension of the General Occupational Well-being Questionnaire (cBLG; Blanch et al.). Total score range: 13 to 91; higher scores indicate greater deterioration of occupational well-being.

    Time frame: At survey completion (single time point)

07

Study locations

6 of 7 sites recruiting
  • Hospital Clinic
    Barcelona, Barcelona, Spain
    Recruiting
    • Noemí Casaponsa · Contactrecerca@csapg.cat · 0034938960025
    • Marta Hage · Principal investigator
  • Sistema d'Emergències Mèdiques de Catalunya
    Barcelona, Barcelona, Spain
    Recruiting
    • Noemí Casaponsa · Contactrecerca@csapg.cat · 0034938960025
    • Mireia Campos · Principal investigator
  • Corporació de Salut del Maresme i la Selva
    Calella, Barcelona, Spain
    Recruiting
    • Noemí Casaponsa · Contactrecerca@csapg.cat · 0034938960025
    • Sergio Bujaldón · Principal investigator
  • Consorci Sanitari de Terrassa
    Terrassa, Barcelona, Spain
    Recruiting
    • Noemí Casaponsa · Contactrecerca@csapg.cat · 0034938960025
    • Clara Romero · Principal investigator
  • Consorci Sanitari de l'Alt Penedès i Garraf
    Vilafranca del Penedès, Barcelona, Spain
    Recruiting
    • Noemí Casaponsa · Contactrecerca@csapg.cat · 0034938960025
    • Genís Cervantes · Principal investigator
  • Institut Català de Salut Àrea Penedès
    Vilafranca del Penedès, Barcelona, Spain
    Recruiting
    • Noemí Casaponsa · Contactrecerca@csapg.cat · 0034938960025
    • Alberto Domínguez · Principal investigator
  • Institut d'Assistència Sanitària
    Girona, Girona, Spain
    Not yet recruiting
    • Noemí Casaponsa · Contactrecerca@csapg.cat · 0034938960025
    • María Cruz Rodríguez · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).

Supporting information: Study protocol

Time frame: After publication of main results of the study

Access criteria: IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2026 (actual). Primary completion is estimated for Dec 2026, 10 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2026
First posted
Nov 9, 2026
StartActual
Feb 24, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07926802
Lead sponsor
Consorci Sanitari de l'Alt Penedès i Garraf
Responsible party
Sponsor
First posted
Nov 9, 2026
Start date
Feb 24, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 9, 2026

Study contacts

Noemí Casaponsa
Contact
recerca@csapg.cat
0034938960025 ext. 43197

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion